5007b22fee53d61876d5d0022e80de59.jpg

The origin of Origin’s 3D printed nasal swabs AM Industry

San Francisco company Origin is one of a handful of 3D printing companies that set out to develop and mass produce 3D printed nasopharyngeal testing swabs for COVID-19 diagnosis. This effort was a direct response to a lack of conventional swabs; stores of the traditional swabs, only produced by a select group of companies around the globe, were rapidly depleted as countries around the world ramped up COVID-19 testing.

2dff959c2150f36886208d21bccc69c6.jpg

BONE 3D delivers open-source swab training model for COVID-19 AM Industry

There is an ongoing need to continue COVID-19 tests around the world, to track how the virus is still spreading and to prevent more major outbreaks. As we learned this week, 3D printing not only has a role to play in the production of medical-grade swabs for COVID-19 diagnostics, but it can also help to train non-medical workers to administer the tests, so that they can be scaled up. Singapore-based Creatz3D recently unveiled a 3D printed manikin designed specifically for COVID-19 swab training, and now French company BONE 3D is also stepping up with its own testing model.

118dc41689fdf6a61526b01f9d11ddb3.jpg

3DBio scales up spheroid bioprinting to accelerate research on anti-COVID-19 drugs Medical

To accelerate the transition from preclinical studies with laboratory animals to clinical studies with humans, specialists at the biotechnological research laboratory 3D Bioprinting Solutions (3DBio) developed a method for the scalable production of 3D spheroids in the quantities necessary to accurately determine the specific activity of pharmacological molecules in the body of COVID-19 infected patients, thus accelerating the discovery process for anti-COVID-19 drugs.